Here is a detailed synthesis of recent research on abnormal CBC patterns, drawn from medical textbooks (Henry's Clinical Diagnosis, Histology Text and Atlas) and the latest peer-reviewed literature (2024-2025):
Abnormal CBC Patterns: A Current Evidence-Based Overview
What the CBC Measures
A CBC is one of the most frequently ordered lab panels. Automated analyzers use flow cytometry to count approximately 10,000 cells per category, generating:
- WBC (total + differential: neutrophils, lymphocytes, monocytes, eosinophils, basophils)
- RBC count, Hemoglobin (Hgb), Hematocrit (HCT)
- Red cell indices: MCV, MCH, MCHC, RDW
- Platelet count
An estimated 10-20% of CBC results are abnormal, and not all require urgent action (Levels.com, 2025).
Red Cell Abnormalities
Anemia (Low Hgb/RBC)
- Men: Hgb <13.5 g/dL | Women: Hgb <12.0 g/dL
- Causes: iron deficiency, B12/folate deficiency, bleeding, hemolysis, chronic disease, bone marrow failure, genetic disorders (sickle cell, thalassemia)
- MCV-based classification drives the workup:
- Microcytic (MCV <80): iron deficiency, thalassemia, lead poisoning
- Normocytic (MCV 80-100): anemia of chronic disease, hemolysis, acute blood loss
- Macrocytic (MCV >100): B12/folate deficiency, liver disease, alcohol use, hypothyroidism
2024 AGA Clinical Practice Update (PMID:
38864796): Iron deficiency anemia is the most common cause and should be evaluated for GI source in adults.
2025 Lancet Haematol Consensus Statement (PMID:
40306833): Provides evidence-based recommendations for iron deficiency management across children, adults, and pregnancy.
Polycythemia (High RBC/Hgb)
- Primary (Polycythemia Vera): JAK2 mutation (>95% of cases); Hgb >16.5 g/dL (men) or >16.0 g/dL (women). Often accompanied by thrombocytosis (53%) and leukocytosis (49%). Risk of thrombosis and transformation to leukemia.
- Secondary: Chronic hypoxia, high altitude, smoking, erythropoietin-secreting tumors.
2025 JAMA Review (PMID:
39556352): All PV patients require therapeutic phlebotomy (target HCT <45%) + low-dose aspirin. Cytoreduction with hydroxyurea or interferon for high-risk cases (age ≥60 or prior thrombosis).
White Cell Abnormalities
Leukocytosis (High WBC)
| Pattern | Common Causes |
|---|
| Neutrophilia | Bacterial infection, stress, corticosteroids, burns, tissue injury, CML |
| Lymphocytosis | Viral infections (EBV, CMV), CLL, pertussis |
| Eosinophilia | Allergies, parasites, drug reactions, Omenn syndrome |
| Monocytosis | Chronic infections (TB), autoimmune disease, recovery from marrow suppression |
| Hyperleukocytosis (>100 × 10⁹/L) | Leukemia - requires urgent hematology referral |
Leukopenia (Low WBC)
- Neutropenia (ANC <500/µL): High infection risk; causes include chemotherapy, radiation, autoimmune disease, aplastic anemia, medications (antipsychotics, antiepileptics), HIV, viral infections
- Chronic neutropenia in African ancestry (Duffy Null phenotype): Benign ethnic neutropenia - long-standing neutropenia without recurrent infections
- Lymphopenia: Primarily reflects T-cell deficiency; seen in HIV, combined immunodeficiencies
Platelet Abnormalities
Thrombocytopenia (Low Platelets, <150 × 10⁹/L)
- Causes: ITP, TTP, HIT, DIC, bone marrow failure, chemotherapy, hypersplenism, viral infections
- Immune TTP (iTTP): Presents with microangiopathic hemolytic anemia (MAHA) + thrombocytopenia. Caused by autoantibodies against ADAMTS13. Life-threatening without treatment (survival <10% untreated vs. ~93% with plasma exchange + corticosteroids + rituximab). More common in females and Black individuals.
- 2025 JAMA Review (PMID: 40388146): Addition of caplacizumab to standard therapy shortens time to platelet normalization and reduces early recurrence, but increases bleeding risk.
- 2025 AABB/ICTMG Guidelines (PMID: 40440268): Updated platelet transfusion thresholds.
Thrombocytosis (High Platelets, >450 × 10⁹/L)
- Reactive (thrombocytosis): Iron deficiency anemia, infection, inflammation, post-splenectomy, surgery, B12/folate deficiency
- Primary (essential thrombocythemia): Genetic mutation in bone marrow; platelets dysfunctional - bleeding risk with extreme counts (≥1000 × 10⁹/L, risk of acquired von Willebrand disease)
Key CBC Indices to Note
| Index | Abnormality | Significance |
|---|
| MCV | Low | Iron deficiency, thalassemia |
| MCV | High | B12/folate, liver disease |
| MCHC | High | Spherocytosis, cold agglutinins, hemolysis |
| RDW | High | Mixed deficiency, early iron deficiency |
| Hypersegmented neutrophils | Present | B12/folate deficiency |
| Schistocytes | Present | Microangiopathic hemolysis (TTP, DIC, HUS) |
| Howell-Jolly bodies | Present | Functional or anatomic asplenia |
Practical Approach to an Abnormal CBC (2025 Oncology Review - Dar, 2025)
- Always compare to previous CBCs - chronicity matters
- Evaluate all three cell lines together - pancytopenia suggests bone marrow pathology
- Order a peripheral blood smear for morphologic clues when the mechanism is unclear
- Refer to hematology when: hyperleukocytosis, unexplained pancytopenia, suspected leukemia/lymphoma, or no response to initial treatment
Sources: Histology: A Text and Atlas (Wolfram Pawlina), Henry's Clinical Diagnosis and Management by Laboratory Methods; PubMed: PMIDs 39556352, 40388146, 40440268, 38864796, 40306833